Loading…
Loading…
REGN · NASDAQ · Healthcare
Side-by-side comparison of key financial metrics between two stocks to identify the better value opportunity.
Market Cap
$78.21B
P/E Ratio
17.36
Forward P/E
—
EPS
$43.07
PEG Ratio
-4.94
Book Value
$298.82
Dividend Yield
0.48%
Profit Margin
31.41%
ROE
14.41%
Use the interactive stock comparison with pre-loaded data for Regeneron Pharmaceuticals Inc. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.
Pre-loaded inputs for REGN: